We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Urinalysis Market Driven by Increasing Burden of UTIs, Diabetes, and Kidney & Liver Diseases

By LabMedica International staff writers
Posted on 22 Dec 2022

The global urinalysis market is projected to reach USD 4. More...

9 billion by 2026, driven by the increasing burden of UTIs, diabetes, and kidney & liver diseases; rising geriatric population and subsequent increase in age-associated diseases and increasing adoption of POC diagnostic tests. Additionally, growth avenues in the emerging economies will provide lucrative opportunities for the players operating in the urinalysis market. These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a market research firm.

The rising geriatric population in the world’s developed and developing regions will positively influence the growth of the global urinalysis market. Due to the rapid growth in the senior population, the prevalence of age-associated diseases such as diabetes, liver, and kidney diseases is expected to increase significantly. The need for diagnosis and management of such diseases is responsible for the increasing number of prescriptions for tests such as creatinine, albumin, glucose, ketones, and bilirubin, etc. These tests are performed by urinalysis and hence, are expected to have a positive impact on the urinalysis market.

However, the availability of refurbished devices could hamper the growth of the urinalysis market as these instruments offer the same functionalities as new equipment at a lower cost. Several end users, mainly small and medium-sized laboratories, opt for cost-effective and refurbished devices. In particular, the markets in developing countries, which are price-sensitive, prefer devices that are cheap and offer similar functionalities. In the absence of well-grounded regulatory frameworks, there could be an influx of low-quality and refurbished urine analyzers into the market. Considering these factors, the demand for refurbished urine analyzers can be expected to increase in the coming years, as these systems offer the same functionalities at a lower cost. This is expected to hamper the revenues of companies offering branded urine analyzers, and thus restrain the overall market growth.

Based on product, the consumables segment accounted for the largest share of the urinalysis market due to frequent purchase of these products on account of their recurrent usage. Based on test type, the sediment urinalysis segment is recording the fastest growth due to the increasing adoption of automated devices for sediment analysis. Based on application, the disease screening segment held the largest share of the urinalysis market due to the increasing incidence of UTIs, diabetes, liver diseases and kidney ailments worldwide. Based on end user, the diagnostic laboratories segment accounted for the largest share of the urinalysis market, owing to the rapidly growing aging population, increasing global incidence of kidney diseases and UTIs, rise in reimbursements for clinical tests performed in hospitals, and launch of advanced urinalysis devices such as integrated devices. Geographically, North America held the largest share of the global urinalysis market owing to the growing geriatric population, favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and availability of technologically advanced instruments in the region.

Related Links:
MarketsandMarkets


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.